Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pancreatitis

Free Subscription Articles published in Ann Surg Retrieve available abstracts of 171 articles: HTML format

Single Articles

July 2024
1. SUZUKI S, Omori Y, Ono Y, Hirose K, et al
   Three Molecular Developmental Pathways of Remnant Pancreatic Cancer after Resection: A Nationwide Project Study of Japan Pancreas Society.
   Ann Surg. 2024 Jul 17. doi: 10.1097/SLA.0000000000006444.
   PubMed     Abstract available
   
   
   
2. SERVIN-ROJAS M, Fong ZV, Fernandez-Del Castillo C, Lionetto G, et al
   Lymph Node Yield is Associated with Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.
   Ann Surg. 2024 Jul 2. doi: 10.1097/SLA.0000000000006432.
   PubMed     Abstract available
   
   
   June 2024
3. MAGNIN J, Jolissaint JS, Fuchs HE, Seier K, et al
   Safety of Selective Operative Drainage After Pancreatic Resection: A Retrospective Analysis of 2,607 Patients.
   Ann Surg. 2024 Jun 28. doi: 10.1097/SLA.0000000000006425.
   PubMed     Abstract available
   
   
   
4. KLOTZ R, Hank T, Berente MP, Joos M, et al
   Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer.
   Ann Surg. 2024 Jun 21. doi: 10.1097/SLA.0000000000006407.
   PubMed     Abstract available
   
   
   
5. LEE JJ, Kearney JF, Trembath HE, Hariharan A, et al
   Tumor-intrinsic and Cancer-associated Fibroblast Subtypes Independently Predict Outcomes in Pancreatic Cancer.
   Ann Surg. 2024 Jun 18. doi: 10.1097/SLA.0000000000006416.
   PubMed     Abstract available
   
   
   
6. WEHRLE CJ, Hossain MS, Perlmutter B, Chang JH, et al
   Consequences of a Surveillance Strategy for Side-Branch Intraductal Pancreatic Mucinous Neoplasms: Long-Term Follow-Up of One-Thousand Cysts.
   Ann Surg. 2024 Jun 6. doi: 10.1097/SLA.0000000000006383.
   PubMed     Abstract available
   
   
   May 2024
7. KASLOW SR, Sharma AR, Hewitt DB, Bridges JFP, et al
   Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous Neoplasms.
   Ann Surg. 2024 May 29. doi: 10.1097/SLA.0000000000006357.
   PubMed     Abstract available
   
   
   
8. KHALILIEH S, Iyer A, Hammelef E, Zohar N, et al
   Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures.
   Ann Surg. 2024 May 22. doi: 10.1097/SLA.0000000000006326.
   PubMed     Abstract available
   
   
   
9. YONKUS JA, Alva-Ruiz R, Colglazier JJ, Kendrick ML, et al
   Outcomes of Visceral Arterial Interposition Graft Reconstruction for Locally Advanced Pancreatic Cancer.
   Ann Surg. 2024 May 21. doi: 10.1097/SLA.0000000000006350.
   PubMed     Abstract available
   
   
   
10. KE L, Ye B, Huang M, Chen T, et al
    Balanced Solution versus Normal Saline in Predicted Severe Acute Pancreatitis: A Stepped Wedge Cluster Randomized Trial.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006319.
    PubMed     Abstract available
    
    
    
11. SCHOUTEN TJ, Kroon VJ, Besselink MG, Bosscha K, et al
    Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic Cancer.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006320.
    PubMed     Abstract available
    
    
    
12. MALLEO G, Lionetto G, Crippa S, Qadan M, et al
    Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis.
    Ann Surg. 2024 May 6. doi: 10.1097/SLA.0000000000006322.
    PubMed     Abstract available
    
    
    
13. JAMES P, Kaushal D, Beaumont Wilson R
    NETosis in Surgery: Pathophysiology, Prevention, and Treatment.
    Ann Surg. 2024;279:765-780.
    PubMed     Abstract available
    
    
    April 2024
14. GAUJOUX S, Regimbeau JM, Piessen G, Truant S, et al
    Somatostatin vs. Octreotide for Prevention of Postoperative Pancreatic Fistula The PREFIPS Randomized Clinical Trial A FRENCH 007 - ACHBT Study.
    Ann Surg. 2024 Apr 25. doi: 10.1097/SLA.0000000000006313.
    PubMed     Abstract available
    
    
    
15. ECKHOFF AM, Fletcher AA, Kelly MS, Dohlman A, et al
    Comprehensive Assessment of the Intrinsic Pancreatic Microbiome.
    Ann Surg. 2024 Apr 16. doi: 10.1097/SLA.0000000000006299.
    PubMed     Abstract available
    
    
    
16. HABIB JR, Rompen IF, Kaslow SR, Grewal M, et al
    Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer: A Multicenter Retrospective Analysis.
    Ann Surg. 2024 Apr 12. doi: 10.1097/SLA.0000000000006295.
    PubMed     Abstract available
    
    
    
17. BRADA LJH, Schouten TJ, Daamen LA, Seelen LWF, et al
    Evaluation of Short- and Long-Term Outcomes After Resection in Patients with Locally Advanced versus (Borderline) Resectable Pancreatic Cancer.
    Ann Surg. 2024 Apr 1. doi: 10.1097/SLA.0000000000006289.
    PubMed     Abstract available
    
    
    March 2024
18. LUCOCQ J, Halle-Smith J, Haugk B, Joseph N, et al
    Long-term Outcomes following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
    Ann Surg. 2024 Mar 22. doi: 10.1097/SLA.0000000000006272.
    PubMed     Abstract available
    
    
    
19. CASS SH, Tzeng CD, Prakash LR, Maxwell J, et al
    Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.
    Ann Surg. 2024 Mar 20. doi: 10.1097/SLA.0000000000006269.
    PubMed     Abstract available
    
    
    
20. CHEN H, Wang W, Fu N, Xia W, et al
    Characterization of Pancreatic Fistula after Post-pancreatectomy Acute Pancreatitis.
    Ann Surg. 2024 Mar 19. doi: 10.1097/SLA.0000000000006277.
    PubMed     Abstract available
    
    
    February 2024
21. BOGGI U, Kauffmann E, Napoli N, Barreto SG, et al
    REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.
    Ann Surg. 2024 Feb 26. doi: 10.1097/SLA.0000000000006248.
    PubMed     Abstract available
    
    
    
22. CHEN H, Wang Y, Jiang K, Xu Z, et al
    The Effect of Perioperative Dexamethasone on Postoperative Complications after Pancreaticoduodenectomy: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2024 Feb 22. doi: 10.1097/SLA.0000000000006240.
    PubMed     Abstract available
    
    
    
23. LI L, Zhang Q, Feng Y, Kong F, et al
    A Novel Serum Exosomal miRNA Signature in the Early Prediction of Persistent Organ Failure in Patients with Acute Pancreatitis.
    Ann Surg. 2024 Feb 7. doi: 10.1097/SLA.0000000000006229.
    PubMed     Abstract available
    
    
    
24. PERRI G, Romandini E, Marchegiani G, Ghorbani P, et al
    Postoperative Hyperamylasemia (POH) is an Early Predictor of Pancreatic Fistula Occurrence and Severity after Distal Pancreatectomy: Results from a European Multicentric Study.
    Ann Surg. 2024 Feb 2. doi: 10.1097/SLA.0000000000006222.
    PubMed     Abstract available
    
    
    January 2024
25. STEIN-THOERINGER CK, Renz BW, De Castilhos J, von Ehrlich-Treuenstatt V, et al
    Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer.
    Ann Surg. 2024 Jan 26. doi: 10.1097/SLA.0000000000006210.
    PubMed     Abstract available
    
    
    
26. OU H, Chen M, Qin K, Zhao S, et al
    Short-term and Long-term Outcomes of Robotic Enucleation of Tumors Located in the Pancreatic Head and Uncinate Process.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006198.
    PubMed     Abstract available
    
    
    
27. SHAH D, Wells A, Cox M, Dawravoo K, et al
    Prospective Evaluation of Circulating Tumor DNA using Next Generation Sequencing as a Biomarker during Neoadjuvant Chemotherapy in Localized Pancreatic Cancer.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006209.
    PubMed     Abstract available
    
    
    
28. KOTECHA K, Tree K, Ziaziaris WA, McKay SC, et al
    Centralization of Pancreaticoduodenectomy: A Systematic Review and Spline Regression Analysis to Recommend Minimum Volume for a Specialist Pancreas Service.
    Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006208.
    PubMed     Abstract available
    
    
    
29. ASSAWASIRISIN C, Qadan M, Aimprasittichai S, Kambadakone A, et al
    Pancreatic Serous Cystadenoma: A Continuing Diagnostic Challenge.
    Ann Surg. 2024 Jan 17. doi: 10.1097/SLA.0000000000006203.
    PubMed    
    
    
    
30. NICKEL F, Kuemmerli C, Muller PC, Schmidt MW, et al
    The PAncreatic Surgery Composite Endpoint PACE - Development and Validation of a Clinically Relevant Endpoint Requiring Lower Sample Sizes.
    Ann Surg. 2024 Jan 12. doi: 10.1097/SLA.0000000000006194.
    PubMed     Abstract available
    
    
    
31. MALLEO G, Casciani F, Lionetto G, Esposito A, et al
    Resection to Exploration Ratios and Associated Outcomes in Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2024 Jan 12. doi: 10.1097/SLA.0000000000006197.
    PubMed     Abstract available
    
    
    December 2023
32. VAN VELDHUISEN CL, Leseman CA, De Rijk FEM, Dekker EN, et al
    Nationwide Outcome of Tailored Surgery for Symptomatic Chronic Pancreatitis based on Pancreatic Morphology: Validation of the International guidelines.
    Ann Surg. 2023 Dec 13. doi: 10.1097/SLA.0000000000006176.
    PubMed     Abstract available
    
    
    
33. THEIJSE RT, Stoop TF, Hendriks TE, Suurmeijer JA, et al
    Nationwide Outcome after Pancreatoduodenectomy in Patients at very High Risk (ISGPS-D) for Postoperative Pancreatic Fistula.
    Ann Surg. 2023 Dec 11. doi: 10.1097/SLA.0000000000006174.
    PubMed     Abstract available
    
    
    
34. ZHU X, Xiao Z, Liu H, Zhang P, et al
    Pancreatic Cancer: An Exocrine Tumor with Endocrine Characteristics.
    Ann Surg. 2023 Dec 5. doi: 10.1097/SLA.0000000000006168.
    PubMed     Abstract available
    
    
    
35. CRIPPA S, Malleo G, Langella S, Ricci C, et al
    Cure Probabilities After Resection Of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis Of 2554 Patients.
    Ann Surg. 2023 Dec 4. doi: 10.1097/SLA.0000000000006166.
    PubMed     Abstract available
    
    
    
36. PERRI G, Marchegiani G, Partelli S, Andreasi V, et al
    Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy.
    Ann Surg. 2023;278:e1242-e1249.
    PubMed     Abstract available
    
    
    November 2023
37. QIN T, Zhang H, Pan S, Liu J, et al
    Effect of Laparoscopic and Open Pancreatoduodenectomy for Pancreatic or Periampullary Tumors: Three-year Follow-up of a Randomized Clinical Trial.
    Ann Surg. 2023 Nov 15. doi: 10.1097/SLA.0000000000006149.
    PubMed     Abstract available
    
    
    
38. VERMA A, Balian J, Hadaya J, Premji A, et al
    Machine Learning Based Prediction of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy.
    Ann Surg. 2023 Nov 10. doi: 10.1097/SLA.0000000000006123.
    PubMed     Abstract available
    
    
    
39. PULVIRENTI A, Javed AA, Michelakos T, Sekigami Y, et al
    Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
    Ann Surg. 2023;278:e1063-e1067.
    PubMed     Abstract available
    
    
    October 2023
40. ROMPEN IF, Levine J, Habib JR, Sereni E, et al
    Progression of Site-Specific Recurrence of Pancreatic Cancer and Implications for Treatment.
    Ann Surg. 2023 Oct 23. doi: 10.1097/SLA.0000000000006142.
    PubMed     Abstract available
    
    
    
41. FUCHS J, Loos M, Kinny-Koster B, Hackert T, et al
    Pancreatic Surgery in Children: Complex, Safe and Effective.
    Ann Surg. 2023 Oct 17. doi: 10.1097/SLA.0000000000006125.
    PubMed     Abstract available
    
    
    
42. QIAO G, Fong ZV, Bolm L, Fernandez Del-Castillo C, et al
    Feasibility, Safety, and Efficacy of Aggressive Multimodal Management of Elderly Patients with Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2023 Oct 13. doi: 10.1097/SLA.0000000000006131.
    PubMed     Abstract available
    
    
    September 2023
43. PAIELLA S, Secchettin E, Lionetto G, Archibugi L, et al
    Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence meta-analysis to Estimate the Rate of low-yield Surgery.
    Ann Surg. 2023 Sep 8. doi: 10.1097/SLA.0000000000006094.
    PubMed     Abstract available
    
    
    August 2023
44. IMAMURA T, Ohgi K, Mori K, Ashida R, et al
    Surrogacy of Recurrence-free Survival for Overall Survival as an Endpoint of Clinical Trials of Perioperative Adjuvant Therapy in Hepatobiliary-pancreatic Cancers: A Retrospective Study and Meta-analysis.
    Ann Surg. 2023 Aug 28. doi: 10.1097/SLA.0000000000006084.
    PubMed     Abstract available
    
    
    
45. VAN DONGEN JC, van Dam JL, Besselink MG, Bonsing BA, et al
    Fistula Risk Score for Auditing Pancreatoduodenectomy: The Auditing-FRS.
    Ann Surg. 2023;278:e272-e277.
    PubMed     Abstract available
    
    
    July 2023
46. ZHANG C, Zironda A, Vierkant RA, Starlinger P, et al
    Quality of Life and Gastrointestinal Symptoms in Long-term Survivors of Pancreatic Cancer Following Pancreatoduodenectomy.
    Ann Surg. 2023 Jul 27. doi: 10.1097/SLA.0000000000006053.
    PubMed     Abstract available
    
    
    
47. SEELEN LWF, Doppenberg D, Stoop TF, Nagelhout A, et al
    Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients with Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006021.
    PubMed     Abstract available
    
    
    
48. MARCINIAK C, Lenne X, Bruandet A, Hamroun A, et al
    Risk-Benefit Balance of Simultaneous Gastric Bypass or Sleeve Gastrectomy and Concomitant Cholecystectomy: A Comprehensive Nationwide Cohort of 289,627 Patients.
    Ann Surg. 2023 Jul 21. doi: 10.1097/SLA.0000000000006039.
    PubMed     Abstract available
    
    
    
49. PECORELLI N, Guarneri G, Vallorani A, Limongi C, et al
    Validation of the PROMIS-29 Questionnaire as a Measure of Recovery after Pancreatic Surgery.
    Ann Surg. 2023 Jul 19. doi: 10.1097/SLA.0000000000006020.
    PubMed     Abstract available
    
    
    
50. VAN GOOR IWJM, Schouten TJ, Verburg DN, Besselink MG, et al
    Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Cohort Study.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006004.
    PubMed     Abstract available
    
    
    
51. VAN VELDHUISEN CL, Sissingh NJ, Boxhoorn L, van Dijk SM, et al
    Long-Term Outcome of Immediate Versus Postponed Intervention in Patients With Infected Necrotizing Pancreatitis (POINTER): Multicenter Randomized Trial.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006001.
    PubMed     Abstract available
    
    
    
52. PODDA M, Di Martino M, Ielpo B, Catena F, et al
    The 2023 MANCTRA Acute Biliary Pancreatitis Care Bundle: A Joint Effort Between Human Knowledge and Artificial Intelligence (ChatGPT) to Optimize the Care of Patients With Acute Biliary Pancreatitis in Western Countries.
    Ann Surg. 2023 Jul 17. doi: 10.1097/SLA.0000000000006008.
    PubMed     Abstract available
    
    
    
53. ABU HILAL M, van Ramshorst TME, Boggi U, Dokmak S, et al
    The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS).
    Ann Surg. 2023 Jul 14. doi: 10.1097/SLA.0000000000006006.
    PubMed     Abstract available
    
    
    
54. VAN OOSTEN AF, Groot VP, Dorland G, Burkhart RA, et al
    Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection.
    Ann Surg. 2023 Jul 3. doi: 10.1097/SLA.0000000000005977.
    PubMed     Abstract available
    
    
    
55. LOOS M, Konig AK, von Winkler N, Mehrabi A, et al
    Completion Pancreatectomy After Pancreatoduodenectomy: Who Needs It?
    Ann Surg. 2023;278:e87-e93.
    PubMed     Abstract available
    
    
    June 2023
56. SNYDER RA, Dueck AC, Fruth B, Shi Q, et al
    Patient-Reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501).
    Ann Surg. 2023 Jun 19. doi: 10.1097/SLA.0000000000005958.
    PubMed     Abstract available
    
    
    
57. PULVIRENTI A, Hauser HF, Fiedler LM, McIntyre CA, et al
    Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
    Ann Surg. 2023 Jun 16. doi: 10.1097/SLA.0000000000005941.
    PubMed     Abstract available
    
    
    
58. ELLIS RJ, Brajcich BC, Bertens KA, Chan CHF, et al
    Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.
    Ann Surg. 2023 Jun 14. doi: 10.1097/SLA.0000000000005955.
    PubMed     Abstract available
    
    
    May 2023
59. SUGAWARA T, Rodriguez Franco S, Sherman S, Torphy RJ, et al
    Neoadjuvant Chemotherapy versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.
    Ann Surg. 2023 May 25. doi: 10.1097/SLA.0000000000005925.
    PubMed     Abstract available
    
    
    
60. NIKIFOROVA MN, Wald AI, Spagnolo DM, Melan MA, et al
    A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising from Pancreatic Cysts.
    Ann Surg. 2023 May 22. doi: 10.1097/SLA.0000000000005904.
    PubMed     Abstract available
    
    
    
61. ARMSTRONG MT, Saadat LV, Chou JF, Gonen M, et al
    Risk Factors for Progression in Patients Undergoing Surveillance for Pancreatic Cysts.
    Ann Surg. 2023 May 22. doi: 10.1097/SLA.0000000000005922.
    PubMed     Abstract available
    
    
    
62. STOOP TF, Bergquist E, Theijse RT, Hempel S, et al
    Systematic review and Meta-analysis of the Role of total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: is it a Justifiable Indication?
    Ann Surg. 2023 May 9. doi: 10.1097/SLA.0000000000005895.
    PubMed     Abstract available
    
    
    April 2023
63. THALJI SZ, Fernando D, Dua KS, Madhavan S, et al
    Biliary Adverse Events during Neoadjuvant Therapy for Pancreatic Cancer.
    Ann Surg. 2023 Apr 20. doi: 10.1097/SLA.0000000000005884.
    PubMed     Abstract available
    
    
    
64. TAKAHASHI H, Akita H, Wada H, Miyata H, et al
    Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients with Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Sett
    Ann Surg. 2023 Apr 14. doi: 10.1097/SLA.0000000000005879.
    PubMed     Abstract available
    
    
    
65. ELSHAMI M, Ammoun AK, Mneimneh WS, Stitzel HJ, et al
    Discordance Between Conventional and Detailed Lymph Node Analysis in Resected, Node-negative Pancreatic or Ampullary Adenocarcinomas and Association with Adverse Survival Outcomes: A Single-institution Analysis.
    Ann Surg. 2023 Apr 13. doi: 10.1097/SLA.0000000000005870.
    PubMed     Abstract available
    
    
    
66. LEONHARDT CS, Pils D, Qadan M, Jomrich G, et al
    The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment.
    Ann Surg. 2023 Apr 12. doi: 10.1097/SLA.0000000000005874.
    PubMed     Abstract available
    
    
    
67. NGO-HUANG AT, Parker NH, Xiao LC, Schadler KL, et al
    Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial.
    Ann Surg. 2023 Apr 7. doi: 10.1097/SLA.0000000000005878.
    PubMed     Abstract available
    
    
    
68. VAN 'T LAND FR, Aziz MH, Michiels N, Mieog JSD, et al
    Increasing Systemic Immune-Inflammation Index During Treatment in Patients with Advanced Pancreatic Cancer is Associated with Poor Survival - A Retrospective, Multicenter, Cohort Study.
    Ann Surg. 2023 Apr 3. doi: 10.1097/SLA.0000000000005865.
    PubMed     Abstract available
    
    
    March 2023
69. LOOS M, Khajeh E, Mehrabi A, Kinny-Koster B, et al
    Distal Pancreatectomy with En-bloc Celiac Axis Resection (dp-car) for Locally Advanced Pancreatic Cancer: A Safe And Effective Procedure.
    Ann Surg. 2023 Mar 30. doi: 10.1097/SLA.0000000000005866.
    PubMed     Abstract available
    
    
    February 2023
70. LEE A, Al-Arnawoot A, Rajendran L, Lamb T, et al
    Feasibility and Safety of a "Shared Care" Model in Complex Hepatopancreatobiliary Surgery: A 5-Year Observational Study of Outcomes in Pancreaticoduodenectomy.
    Ann Surg. 2023 Feb 20. doi: 10.1097/SLA.0000000000005826.
    PubMed     Abstract available
    
    
    
71. SCHOUTEN TJ, Henry AC, Smits FJ, Besselink MG, et al
    Risk Models for Developing Pancreatic Fistula after Pancreatoduodenectomy: Validation in a Nationwide Prospective Cohort.
    Ann Surg. 2023 Feb 20. doi: 10.1097/SLA.0000000000005824.
    PubMed     Abstract available
    
    
    
72. DREYER SB, Rae S, Bisset K, Upstill-Goddard R, et al
    The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer.
    Ann Surg. 2023;277:e396-e405.
    PubMed     Abstract available
    
    
    January 2023
73. LIANG T, Zhang Q, Wu G, Liu C, et al
    Radical Resection Combined with Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer after Neoadjuvant Therapy: A Report of 36 Consecutive Cases.
    Ann Surg. 2023 Jan 24. doi: 10.1097/SLA.0000000000005797.
    PubMed     Abstract available
    
    
    
74. VAN DEN BROEK BLJ, Zwart MJW, Bonsing BA, Busch OR, et al
    Video Grading of Pancreatic Anastomoses During Robotic Pancreatoduodenectomy to Assess both Learning Curve and the Risk of Pancreatic Fistula - A Post Hoc Analysis of the LAELAPS-3 Training Program.
    Ann Surg. 2023 Jan 20. doi: 10.1097/SLA.0000000000005796.
    PubMed     Abstract available
    
    
    
75. TIMMERHUIS HC, van den Berg FF, Noorda PC, van Dijk SM, et al
    Over- and Misuse of Antibiotics and the Clinical Consequence in Necrotizing Pancreatitis: An Observational Multicenter Study.
    Ann Surg. 2023 Jan 3. doi: 10.1097/SLA.0000000000005790.
    PubMed     Abstract available
    
    
    December 2022
76. NEWHOOK TE, Vreeland TJ, Griffin JF, Tidwell RSS, et al
    Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
    Ann Surg. 2022 Dec 26. doi: 10.1097/SLA.0000000000005184.
    PubMed     Abstract available
    
    
    
77. NISHIWADA S, Cui Y, Sho M, Jun E, et al
    Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022;276:e876-e885.
    PubMed     Abstract available
    
    
    November 2022
78. KULKARNI S, Parina R, Henderson R, Derek E, et al
    Transfusion-Free Strategies in Liver and Pancreatic Surgery: A Predictive Model of Blood Conservation for Transfusion Avoidance in Mainstream Populations.
    Ann Surg. 2022 Nov 17. doi: 10.1097/SLA.0000000000005757.
    PubMed     Abstract available
    
    
    
79. KASLOW SR, Sacks GD, Berman RS, Lee AY, et al
    Natural History of Stage IV Pancreatic Cancer. Identifying Survival Benchmarks for Curative-intent Resection in Patients With Synchronous Liver-only Metastases.
    Ann Surg. 2022 Nov 10. pii: 00000658-990000000-00312.
    PubMed     Abstract available
    
    
    September 2022
80. BALZANO G, Zerbi A, Aleotti F, Capretti G, et al
    Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial.
    Ann Surg. 2022 Sep 30. pii: 00000658-990000000-00269.
    PubMed     Abstract available
    
    
    
81. JAVED AA, Ding D, Hasanain A, van Oosten F, et al
    Persistent Circulating Tumor Cells at One Year after Oncologic Resection Predict Late Recurrence in Pancreatic Cancer.
    Ann Surg. 2022 Sep 15. pii: 00000658-990000000-00263.
    PubMed     Abstract available
    
    
    
82. JAVED AA, Floortje van Oosten A, Habib JR, Hasanain A, et al
    A Delay in Adjuvant Therapy is Associated with Worse Prognosis only in Patients with Transitional Circulating Tumor Cells Following Resection of Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022 Sep 15. pii: 00000658-990000000-00264.
    PubMed     Abstract available
    
    
    
83. DEMYAN L, Habowski AN, Plenker D, King DA, et al
    Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
    Ann Surg. 2022;276:450-462.
    PubMed     Abstract available
    
    
    August 2022
84. KHACHFE HH, Nassour I, Hammad AY, Hodges JC, et al
    Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes - Is Laparoscopy Still Justified?
    Ann Surg. 2022 Aug 24. pii: 00000658-990000000-00239.
    PubMed     Abstract available
    
    
    
85. ECKER BL, Dickinson SM, Saadat LV, Tao AJ, et al
    Segmental vs. Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.
    Ann Surg. 2022 Aug 11. pii: 00000658-990000000-00228.
    PubMed     Abstract available
    
    
    
86. SEELEN LWF, Floortje van Oosten A, Brada LJH, Groot VP, et al
    Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter Study.
    Ann Surg. 2022 Aug 11. pii: 00000658-990000000-00226.
    PubMed     Abstract available
    
    
    
87. PARTELLI S, Muffatti F, Andreasi V, Giannone F, et al
    A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2022 Aug 5. pii: 00000658-990000000-00213.
    PubMed     Abstract available
    
    
    
88. WEI AC, Jarnagin WR
    Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria: Not So Simple.
    Ann Surg. 2022;276:222-223.
    PubMed    
    
    
    
89. BOLM L, Pisuchpen N, Qadan M, Kambadakone A, et al
    Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria.
    Ann Surg. 2022;276:215-221.
    PubMed     Abstract available
    
    
    July 2022
90. MERDRIGNAC A, Garnier J, Dokmak S, Regenet N, et al
    Effect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula after Distal Pancreatectomy: Results of the REPLAY Multicenter Randomized clinical trial REPLAY: REinforcement of the Pancreas in distaL pAncreatectomY.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00185.
    PubMed     Abstract available
    
    
    
91. BANNONE E, Marchegiani G, Vollmer C, Perri G, et al
    Postoperative Serum Hyperamylasemia (POH) Adds Sequential Value to the Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after Pancreatoduodenectomy.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00182.
    PubMed     Abstract available
    
    
    
92. TIMMERHUIS HC, van Dijk SM, Hollemans RA, Umans DS, et al
    Perforation and Fistula of the Gastrointestinal Tract in Patients with Necrotizing Pancreatitis: a Nationwide Prospective Cohort.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00174.
    PubMed     Abstract available
    
    
    
93. SUURMEIJER JA, Henry AC, Bonsing BA, Bosscha K, et al
    Outcome of Pancreatic Surgery During the First Six Years of a Mandatory Audit within the Dutch Pancreatic Cancer Group.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00173.
    PubMed     Abstract available
    
    
    
94. CHEN H, Wang C, Shen Z, Wang W, et al
    Post-pancreatectomy Acute Pancreatitis after Pancreaticoduodenectomy: A Distinct Clinical Entity.
    Ann Surg. 2022 Jul 18. pii: 00000658-990000000-00161.
    PubMed     Abstract available
    
    
    
95. KINNY-KOSTER B, Habib JR, van Oosten AF, Javed AA, et al
    Conduits in Vascular Pancreatic Surgery: Analysis of Clinical Outcomes, Operative Techniques and Graft Performance.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00153.
    PubMed     Abstract available
    
    
    
96. POULSON MR, Papageorge MV, LaRaja AS, Kenzik KM, et al
    Socioeconomic Mediation of Racial Segregation in Pancreatic Cancer Treatment and Outcome Disparities.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00136.
    PubMed     Abstract available
    
    
    
97. HACKERT T, Klaiber U, Hinz U, Strunk S, et al
    Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00058.
    PubMed     Abstract available
    
    
    
98. YAO J, Cao K, Hou Y, Zhou J, et al
    Deep Learning for Fully Automated Prediction of Overall Survival in Patients Undergoing Resection for Pancreatic Cancer: A Retrospective Multicenter Study.
    Ann Surg. 2022 Jul 4. pii: 00000658-990000000-00053.
    PubMed     Abstract available
    
    
    June 2022
99. CHINNAKOTLA S, Beilman GJ, Vock D, Freeman ML, et al
    Intraportal Islet Autotransplantation Independently Improves Quality of Life after Total Pancreatectomy in Patients with Chronic Refractory Pancreatitis.
    Ann Surg. 2022 Jun 28. pii: 00000658-990000000-00030.
    PubMed     Abstract available
    
    
    
100. HANK T, Klaiber U, Hinz U, Schutte D, et al
     Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer.
     Ann Surg. 2022 Jun 27. pii: 00000658-990000000-00016.
     PubMed     Abstract available
     
     
     
101. BOLM L, Nebbia M, Wei AC, Zureikat AH, et al
     Long Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients with Non-Functional Pancreatic Neuroendocrine Tumors <3cm in a Large Multi-Center Cohort.
     Ann Surg. 2022 Jun 27. pii: 00000658-990000000-00029.
     PubMed     Abstract available
     
     
     March 2022
102. YAMAGUCHI J, Yokoyama Y, Fujii T, Yamada S, et al
     Results of a Phase II Study on the use of Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine with nab-paclitaxel) for Borderline-Resectable Pancreatic Cancer (NUPAT-01).
     Ann Surg. 2022 Mar 3. pii: 00000658-900000000-93060.
     PubMed     Abstract available
     
     
     
103. DA COSTA WL JR, Tran Cao HS, Gu X, Massarweh NN, et al
     Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
     Ann Surg. 2022;275:415-421.
     PubMed     Abstract available
     
     
     
104. SCHULICK RD
     Commentary on "Laparoscopic Pancreaticoduodenectomy With Transanal Specimen Extraction for Periampullary Tumors".
     Ann Surg. 2022;275:e599.
     PubMed    
     
     
     February 2022
105. BOECK S, Heinemann V, Werner J
     Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
     Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93084.
     PubMed    
     
     
     
106. DAAMEN LA, Groot VP, Verkooijen HM, Molenaar IQ, et al
     Response to: Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
     Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93083.
     PubMed    
     
     
     January 2022
107. JAVED AA, Pulvirenti A, Razi S, Zheng J, et al
     Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.
     Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93105.
     PubMed     Abstract available
     
     
     
108. OMIYA K, Oba A, Inoue Y, Kobayashi K, et al
     Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Non-secretors with Pancreatic Cancer.
     Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93098.
     PubMed     Abstract available
     
     
     
109. 
     Root-cause Analysis of Mortality After Pancreatic Resection (CARE Study): A Multicenter Cohort Study: Erratum.
     Ann Surg. 2022;275:e280.
     PubMed    
     
     
     December 2021
110. JANSSEN BV, Verhoef S, Wesdorp NJ, Huiskens J, et al
     Imaging-based Machine-learning Models to Predict Clinical Outcomes and Identify Biomarkers in Pancreatic Cancer: A Scoping Review.
     Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93137.
     PubMed     Abstract available
     
     
     
111. LOPEZ-VERDUGO F, Fong ZV, Lillemoe KD, Blaszkowsky LS, et al
     Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy.
     Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93135.
     PubMed     Abstract available
     
     
     
112. NAGAKAWA Y, Jang JY, Kawai M, Kim SC, et al
     Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
     Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93153.
     PubMed     Abstract available
     
     
     
113. CLARKE CN, Maduekwe UN
     Commentary on Brief Clinical Report: "Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreaticoduodenectomy: A pilot series".
     Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93145.
     PubMed    
     
     
     
114. HUANG L, Jansen L, Balavarca Y, van der Geest L, et al
     Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
     Ann Surg. 2021;274:e554-e563.
     PubMed     Abstract available
     
     
     November 2021
115. BEDNAR F
     Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer.
     Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93186.
     PubMed    
     
     
     
116. HUSCHER C, Perri G, Lazzarin G, Marchegiani G, et al
     Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreatoduodenectomy: A Pilot Series.
     Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93185.
     PubMed     Abstract available
     
     
     
117. GARAJOVA I, Balsano R, Donati V, Gnetti L, et al
     Comment on "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al."
     Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93189.
     PubMed    
     
     
     
118. DAYYEH BKA, Chandrasekhara V, Shah RJ, Easler JJ, et al
     Combined Drainage and Protocolized Necrosectomy Through a Co-axial Lumen-Apposing Metal Stent for Pancreatic Walled-off Necrosis: A Prospective Multicenter Trial.
     Ann Surg. 2021 Nov 2. pii: 00000658-900000000-93212.
     PubMed     Abstract available
     
     
     October 2021
119. KEMPENEERS MA, Issa Y, Bruno MJ, van Santvoort HC, et al
     Cost-Effectiveness of Early Surgery Versus Endoscopy-First Approach for Painful Chronic Pancreatitis in the ESCAPE Trial.
     Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93237.
     PubMed     Abstract available
     
     
     
120. DALMACY D, Paro A, Hyer JM, Obeng-Gyasi S, et al
     Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Treatment Among Patients Diagnosed with Pancreatic Adenocarcinoma.
     Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93235.
     PubMed     Abstract available
     
     
     September 2021
121. MARCHEGIANI G, Barreto SG, Bannone E, Sarr M, et al
     Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS).
     Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93261.
     PubMed     Abstract available
     
     
     August 2021
122. LIU Q, Zhao Z, Zhang X, Wang W, et al
     Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.
     Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93318.
     PubMed     Abstract available
     
     
     
123. ROLDAN J, Harrison JM, Qadan M, Bolm L, et al
     "Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience with 1290 Resections".
     Ann Surg. 2021 Aug 4. pii: 00000658-900000000-93359.
     PubMed     Abstract available
     
     
     July 2021
124. BIRRER DL, Golcher H, Casadei R, Haile SR, et al
     Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data from Three Randomized Controlled Trials.
     Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93387.
     PubMed     Abstract available
     
     
     
125. BEUGNIEZ C, Sauvanet A, Sulpice L, Gaujoux S, et al
     Root-Cause Analysis of Mortality Following Pancreatic Resection (CARE Study): A Multicenter Cohort Study.
     Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93374.
     PubMed     Abstract available
     
     
     
126. BRADA LJH, Daamen LA, Magermans LG, Walma MS, et al
     Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer Following Upfront FOLFIRINOX versus FOLFIRINOX Only: Multicenter Propensity Score-Matched Analysis.
     Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93372.
     PubMed     Abstract available
     
     
     
127. JOLISSAINT JS, Reyngold M, Bassmann J, Seier KP, et al
     Local Control and Survival after Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma with Vascular Involvement.
     Ann Surg. 2021 Jul 16. pii: 00000658-900000000-93409.
     PubMed     Abstract available
     
     
     
128. MAATMAN TK, McGuire SP, Flick KF, Madison MK, et al
     Outcomes in Endoscopic and Operative Transgastric Pancreatic Debridement.
     Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93434.
     PubMed     Abstract available
     
     
     
129. YEO TP, Fogg RW, Shimada A, Marchesani N, et al
     The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic.
     Ann Surg. 2021 Jul 2. pii: 00000658-900000000-93452.
     PubMed     Abstract available
     
     
     
130. BLAIR AB, Yin LD, Pu N, Yu J, et al
     Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer.
     Ann Surg. 2021;274:162-169.
     PubMed     Abstract available
     
     
     June 2021
131. HESTER CA, Kothari AN, Mason M, Maxwell J, et al
     Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients with Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.
     Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93456.
     PubMed     Abstract available
     
     
     
132. DAI M, Liu Q, Xing C, Tian X, et al
     Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial.
     Ann Surg. 2021 Jun 11. pii: 00000658-900000000-93510.
     PubMed     Abstract available
     
     
     April 2021
133. BANNONE E, Marchegiani G, Balduzzi A, Procida G, et al
     Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity after Pancreatic Surgery.
     Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93565.
     PubMed     Abstract available
     
     
     
134. GIULIANI T, De Pastena M, Paiella S, Marchegiani G, et al
     Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis.
     Ann Surg. 2021 Apr 14. pii: 00000658-900000000-93588.
     PubMed     Abstract available
     
     
     
135. HABIB JR, Kinny-Koster B, Bou-Samra P, Alsaad R, et al
     Surgical Decision Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
     Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93602.
     PubMed     Abstract available
     
     
     
136. MENG H, Wang S, Liu J, Zhao X, et al
     Laparoscopic Pancreaticoduodenectomy with Transanal Specimen Extraction for Periampullary Tumors.
     Ann Surg. 2021 Apr 7. pii: 00000658-900000000-93576.
     PubMed     Abstract available
     
     
     
137. HACKERT T, Buchler MW
     Respone to: Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
     Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004872.
     PubMed    
     
     
     
138. LINDEMANN J, Toit LD, Krige J, Jonas E, et al
     Comment on: Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
     Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004877.
     PubMed    
     
     
     March 2021
139. SCHUH F, Mihaljevic AL, Probst P, Trudeau MT, et al
     A Simple Classification Of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery (ISGPS).
     Ann Surg. 2021 Mar 12. doi: 10.1097/SLA.0000000000004855.
     PubMed     Abstract available
     
     
     
140. MARCHEGIANI G, Perri G, Burelli A, Zoccatelli F, et al
     High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
     Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004840.
     PubMed     Abstract available
     
     
     
141. HANK T, Hinz U, Reiner T, Malleo G, et al
     A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer.
     Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004845.
     PubMed     Abstract available
     
     
     February 2021
142. LOOS M, Hackert T, Buchler MW
     Response to Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
     Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93709.
     PubMed    
     
     
     
143. REAMES BN, Ejaz A, Weiss MJ
     Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
     Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93707.
     PubMed    
     
     
     January 2021
144. BEGER HG, Mayer B, Vasilescu C, Poch B, et al
     Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
     Ann Surg. 2021 Jan 15. doi: 10.1097/SLA.0000000000004757.
     PubMed     Abstract available
     
     
     
145. VAN DEN BERG FF, Issa Y, Vreijling JP, Lerch MM, et al
     Whole-Exome Sequencing Identifies SLC52A1 and ZNF106 Variants as Novel Genetic Risk Factors for (Early) Multiple-Organ Failure in Acute Pancreatitis.
     Ann Surg. 2021;Publish Ahead of Print.
     PubMed     Abstract available
     
     
     
146. ADDEO P, Averous G, Bachellier P
     Response to Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
     Ann Surg. 2021 Jan 1. pii: 00000658-900000000-93782.
     PubMed    
     
     
     December 2020
147. QING Z, Liu ZY, Chen QY, Huang CM, et al
     Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
     Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.
     PubMed    
     
     
     
148. HEWITT DB, Nissen N, Hatoum H, Musher B, et al
     A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
     Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004669.
     PubMed     Abstract available
     
     
     
149. GIBOR U, Perry Z, Netz U, Kirshtein B, et al
     Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time-A Prospective Cohort Study.
     Ann Surg. 2020;Publish Ahead of Print.
     PubMed     Abstract available
     
     
     
150. SUGUMAR K, Hue JJ, Ahorukomeye P, Rothermel LD, et al
     Defining Common Features in High Impact and Highly Cited Journal Articles on Pancreatic Tumors: An Analysis of 1044 Studies over the Past Decade.
     Ann Surg. 2020;Publish Ahead of Print.
     PubMed     Abstract available
     
     
     
151. DE GEUS SWL, Hachey KJ, Nudel JD, Ng SC, et al
     Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers.
     Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004432.
     PubMed     Abstract available
     
     
     
152. VERSTEIJNE E, Suker M, Groen JV, Besselink MG, et al
     External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible But Non-Randomized Patients.
     Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004364.
     PubMed     Abstract available
     
     
     November 2020
153. HUNGER R, Mantke R
     Outcome Quality Beyond the Mean - An Analysis of 43,231 Pancreatic Surgical Procedures Related to Hospital Volume.
     Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004315.
     PubMed     Abstract available
     
     
     
154. LOF S, Korrel M, Besselink MG, Abu Hilal M, et al
     Response to Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study".
     Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004279.
     PubMed    
     
     
     
155. CHEN B, Li G, Cheng W, Chen M, et al
     Comment On: Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
     Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004621.
     PubMed    
     
     
     
156. ZYROMSKI NJ, Maatman TK
     Response to Letter to Editor Regarding: "Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes" (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468).
     Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004622.
     PubMed    
     
     
     
157. ROBERTSON FP, Ravikumar R, Wigmore SJ
     Comment on: Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?
     Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004536.
     PubMed    
     
     
     
158. ZHANG XP, Zhao GD, Liu R
     Comment On "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
     Ann Surg. 2020 Nov 16. doi: 10.1097/SLA.0000000000004410.
     PubMed    
     
     
     
159. RAMIREZ-MALDONADO E, Gordo SL, Pueyo EM, Sanchez-Garcia A, et al
     Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial).
     Ann Surg. 2020 Nov 13. doi: 10.1097/SLA.0000000000004596.
     PubMed     Abstract available
     
     
     
160. VAN DONGEN JC, Suker M, Versteijne E, Bonsing BA, et al
     Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
     Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004313.
     PubMed     Abstract available
     
     
     
161. MALLEO G, Maggino L, Qadan M, Marchegiani G, et al
     Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
     Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004552.
     PubMed     Abstract available
     
     
     October 2020
162. HUANG L
     Response to the: Comment on "Optimal Number of Examined Lymph Node May Depend on Age in Patients with Pancreatic Adenocarcinoma".
     Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004449.
     PubMed    
     
     
     
163. CRIPPA S, Pergolini I, Javed AA, Honselmann KC, et al
     Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.
     Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004464.
     PubMed     Abstract available
     
     
     
164. DATTA J, Wilson GC, D'Angelica MI, Katz MH, et al
     A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak.
     Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004471.
     PubMed    
     
     
     
165. MAATMAN TK, Ceppa EP, Fogel EL, Easler JJ, et al
     Biliary Stricture after Necrotizing Pancreatitis: An Underappreciated Challenge.
     Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004470.
     PubMed     Abstract available
     
     
     
166. CHAWLA A, Qadan M, Castillo CF, Wo JY, et al
     Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
     Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004585.
     PubMed     Abstract available
     
     
     
167. XU HX, Li S, Xu SS, Liu L, et al
     Comments on "Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer".
     Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004538.
     PubMed    
     
     
     
168. TAKAHASHI S, Ohno I, Ikeda M, Konishi M, et al
     Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05).
     Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004535.
     PubMed     Abstract available
     
     
     
169. SCHULICK RD, Oba A, Del Chiaro M
     Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
     Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004275.
     PubMed    
     
     
     September 2020
170. HU HJ, Cheng NS, Li FY
     Comment on: Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
     Ann Surg. 2020 Sep 29. doi: 10.1097/SLA.0000000000004283.
     PubMed    
     
     
     June 2020
171. LOOS M, Kester T, Klaiber U, Mihaljevic AL, et al
     Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.
     Ann Surg. 2020 Jun 12. doi: 10.1097/SLA.0000000000004054.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.